SG Americas Securities LLC lowered its position in CryoLife, Inc. (NYSE:CRY) by 17.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,635 shares of the medical equipment provider’s stock after selling 1,369 shares during the period. SG Americas Securities LLC’s holdings in CryoLife were worth $110,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Dimensional Fund Advisors LP raised its stake in shares of CryoLife by 8.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,749,123 shares of the medical equipment provider’s stock worth $33,496,000 after buying an additional 131,597 shares during the last quarter. State Street Corp raised its stake in shares of CryoLife by 19.4% in the fourth quarter. State Street Corp now owns 694,877 shares of the medical equipment provider’s stock worth $13,308,000 after buying an additional 112,966 shares during the last quarter. FMR LLC raised its stake in shares of CryoLife by 19.8% in the fourth quarter. FMR LLC now owns 479,081 shares of the medical equipment provider’s stock worth $9,174,000 after buying an additional 79,081 shares during the last quarter. Guggenheim Capital LLC bought a new stake in shares of CryoLife during the fourth quarter worth approximately $1,243,000. Finally, Russell Investments Group Ltd. bought a new stake in shares of CryoLife during the fourth quarter worth approximately $882,000. Institutional investors and hedge funds own 68.17% of the company’s stock.

Shares of CryoLife, Inc. (CRY) opened at 19.65 on Tuesday. The company’s 50 day moving average is $18.79 and its 200-day moving average is $17.93. CryoLife, Inc. has a one year low of $11.81 and a one year high of $20.30. The firm has a market capitalization of $653.56 million, a price-to-earnings ratio of 63.80 and a beta of 0.99.

CryoLife (NYSE:CRY) last released its quarterly earnings data on Wednesday, April 26th. The medical equipment provider reported $0.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.04 by $0.05. CryoLife had a net margin of 5.73% and a return on equity of 7.77%. The firm had revenue of $45.10 million for the quarter, compared to the consensus estimate of $44.64 million. During the same quarter in the prior year, the company posted $0.10 earnings per share. The business’s revenue was up 4.9% on a year-over-year basis. Equities analysts expect that CryoLife, Inc. will post $0.43 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “SG Americas Securities LLC Lowers Position in CryoLife, Inc. (NYSE:CRY)” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/07/18/sg-americas-securities-llc-lowers-position-in-cryolife-inc-nysecry.html.

A number of equities research analysts recently commented on CRY shares. Zacks Investment Research upgraded shares of CryoLife from a “hold” rating to a “buy” rating and set a $21.00 price objective on the stock in a report on Thursday, June 8th. Northland Securities restated a “buy” rating and set a $23.50 price objective on shares of CryoLife in a report on Friday, April 28th. Five analysts have rated the stock with a buy rating, CryoLife has a consensus rating of “Buy” and an average target price of $20.80.

In other CryoLife news, VP Amy Horton sold 9,577 shares of the company’s stock in a transaction on Tuesday, June 27th. The shares were sold at an average price of $20.00, for a total transaction of $191,540.00. Following the transaction, the vice president now owns 112,282 shares in the company, valued at $2,245,640. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 6.00% of the company’s stock.

CryoLife Company Profile

CryoLife, Inc (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix.

Want to see what other hedge funds are holding CRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoLife, Inc. (NYSE:CRY).

Institutional Ownership by Quarter for CryoLife (NYSE:CRY)

Receive News & Ratings for CryoLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.